The molecular arms race between African trypanosomes and humans

Nat Rev Microbiol. 2014 Aug;12(8):575-84. doi: 10.1038/nrmicro3298. Epub 2014 Jun 30.

Abstract

Humans can survive bloodstream infection by African trypanosomes, owing to the activity of serum complexes that have efficient trypanosome-killing ability. The two trypanosome subspecies that are responsible for human sleeping sickness--Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense--can evade this defence mechanism by expressing distinct resistance proteins. In turn, sequence variation in the gene that encodes the trypanosome-killing component in human serum has enabled populations in western Africa to restore resistance to T. b. rhodesiense, at the expense of the high probability of developing kidney sclerosis. These findings highlight the importance of resistance to trypanosomes in human evolution.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apolipoprotein L1
  • Apolipoproteins / genetics
  • Apolipoproteins / metabolism
  • Biological Evolution
  • Disease Resistance / immunology
  • Humans
  • Lipoproteins, HDL / genetics
  • Lipoproteins, HDL / metabolism
  • Trypanosoma brucei gambiense / immunology*
  • Trypanosoma brucei gambiense / metabolism
  • Trypanosoma brucei rhodesiense / immunology*
  • Trypanosoma brucei rhodesiense / metabolism
  • Trypanosomiasis, African / genetics
  • Trypanosomiasis, African / immunology*
  • Trypanosomiasis, African / metabolism

Substances

  • APOL1 protein, human
  • Apolipoprotein L1
  • Apolipoproteins
  • Lipoproteins, HDL